A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.

PLoS One · 2015 · PMC4368639 · PMID 25793508

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Interim reports on the immunogenicity of an Sf9 (insect cell)-produced RSV F subunit vaccine in human subjects 60 years and older show only a slight trend to better serological responses in alum adjuvanted compared to unadjuvanted groups [ 55 ].

also in 2,443 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.